U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Approval Year

Substance Class
Concept
Record UNII
CTG26PRE5S
Record Status Validated (UNII)
Record Version
  • Download
Name Type Language
FP-1039
Code English
FGF RECEPTOR ANTAGONIST HGS1036
Common Name English
HGS-1036
Common Name English
A SOLUBLE FUSION PROTEIN CONSISTING OF FIBROBLAST GROWTH FACTOR RECEPTOR 1 AND FC DOMAIN OF IGG1
Common Name English
GSK3052230
Code English
FP 1039 [WHO-DD]
Common Name English
HGS1036
Code English
FP1039
Code English
GSK-3052230
Code English
Classification Tree Code System Code
NCI_THESAURUS C155727
Created by admin on Sat Dec 16 12:48:30 GMT 2023 , Edited by admin on Sat Dec 16 12:48:30 GMT 2023
NCI_THESAURUS C1742
Created by admin on Sat Dec 16 12:48:30 GMT 2023 , Edited by admin on Sat Dec 16 12:48:30 GMT 2023
Code System Code Type Description
NCI_THESAURUS
C77970
Created by admin on Sat Dec 16 12:48:30 GMT 2023 , Edited by admin on Sat Dec 16 12:48:30 GMT 2023
PRIMARY NCIT
FDA UNII
CTG26PRE5S
Created by admin on Sat Dec 16 12:48:30 GMT 2023 , Edited by admin on Sat Dec 16 12:48:30 GMT 2023
PRIMARY
CAS
1631072-93-9
Created by admin on Sat Dec 16 12:48:30 GMT 2023 , Edited by admin on Sat Dec 16 12:48:30 GMT 2023
PRIMARY
This is a non-substance concept
Related Record Type Details
TARGET -> INHIBITOR
Prevents FGFR ligands, such as FGF1, FGF2, FGF4, from binding to their cognate receptors, thereby inhibiting the activation of the related FGFR tyrosine kinases. Inhibition of FGFR1 by this agent may retard tumor cell proliferation and induce tumor cell death. FP-1039 may also inhibit vascular endothelial growth factor (VEGF)-induced angiogenesis. FGFR1 is a receptor tyrosine kinase upregulated in certain tumor cells and involved in tumor cellular proliferation, differentiation, angiogenesis, and survival; most ligands that bind to FGFR1 also bind to the related receptors FGFR3 and FGFR4.
Related Record Type Details
ACTIVE MOIETY
This is a non-substance concept